Effects of inulin fibre supplementation on serum glucose and lipid concentration in patients with type 2 diabetes

International Journal of Diabetes and Metabolism

Volumn 20, Issue 3, 2012, Pages 80-86

  Bonsu, Nana K A ^a   Johnson, Shanthi ^a  

^a UNIVERSITY OF REGINA   (Canada)

Author keywords

Diabetes; Fibre; Inulin; Serum cholesterol; Serum glucose

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INULIN; PLACEBO; TRIACYLGLYCEROL; XYLITOL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84874052283     PISSN: 16067754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Diabetes in Canada: Highlights from the National Diabetes Surveillance System: Public Health Agency of Canada, 2008. (Accessed March 1, 2011, at http://www.phacaspc.gc.ca/publicat/2008/dicndssdacsnsd-04-05/pwdd-iaddeng.php#tab1.
2. It's your health: Type 2 diabetes: Health Canada., 2006. Accessed November 5, 2 http://www.hcsc.gc.ca/iyhvsv/alt_formats/cmcddcmc/pdf/diabete_e.pdf.
3. Selected leading causes of death, by sex: Statistics Canada, 2005. (Accessed November 5, 2010, at http://www40.statcan.ca/l01/cst01/health36.htm.)
4. Tirosh A, Shai I, Tekes-Manova D, Iraeli E, Pereg D, Shochat T, Kochba I, Rudich A. Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 2009; 353: 1454-1462.
5. Krentz AJ. Lipoprotein abnormalities and their consequences for patients with type 2 diabetes. Diabetes Obes Metab 2003; 5: S19-S27.
6. Turner RC, Mills H, Neil HAW, Stratton IM, Manley SE, Matthews DR, Holman RR. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23). Br Med J 1998; 316: 823-828.
7. Gannon MC, Nuttall FQ. Control of blood glucose in type 2 diabetes without weight loss by modification of diet composition. Nutr Metab 2006; 3: 16-23.
8. Weicker MO, Pfeiffer AFH. Metabolic effects of dietary fiber consumption and prevention of diabetes. J Nutr 2008; 138: 439-442.
9. Schneeman BO. Fibre, inulin and oligofructose: Similarities and differences. J Nutr 1999; 129: 1424S--1427S.
10. Fibre up!: Dietitians of Canada, 2007. Accessed November 20, 2010, at (http://www.dietitians.ca/news/frm_resource/imageser ver.asp?id=835&document_type=document&popup=true&contentid=8370.)
11. Engel, JV. The benefits of eating fibre. 2007. (Accessed November 18, 2010, at http://www.diabetes.ca/section_about/fibre.asp.)
12. Kaur N, Gupta AK. Applications of inulin and oligofructose in health and nutrition. J Biosci 2002; 27: 703-714.
13. Panel on the definition of dietary fiber, Standing committee on the scientific evaluation of dietary reference intakes, & Food and nutrition board. Dietary reference intakes: Proposed definition of dietary fibre. Washington, D.C.: National Academy of Sciences, 2001
14. Alles MS, de Roos NM, Bakx JC, van de Lisdonik E, Zock PL, Hautvast JGAJ. Consumption of fructoologosaccharides does not favorably affect blood glucose and serum lipid concentrations in patients with type 2 diabetes. Am J Clin Nutr 1999; 69: 64-69.
15. Venter CS, Vorster HH, Cummings JH. Effects of dietary propionate on carbohydrate and lipid metabolism in healthy volunteers. Am J Gastroenterol 1990; 85: 549-553.
16. Beylot M. Effects of inulin-type fructans on lipid metabolism in animal and human beings. Br J Nutr 2005; 93: S163-S168.
17. Yamashita K, Kawai K, Itakura K. Effect of fructooligosaccharides on blood glucose and serum lipids in diabetic subjects. Nutr Res 1984; 4: 961-966.
18. Luo J, Van Yperselle M, Rizkally S, Ross F, Bornet F, Slama G. Chronic consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin-resistance in type 2 diabetes. J Nutr 2000; 130: 1572-1577.
19. Delzenne N., Cani P D, Neyrinck AM. Modulation of glucagon-like peptide 1 and energy metabolism by inulin and oligofructose: Experimental data. J Nutr 2007; 137: 2547S-2551S.
20. Daubioul CA, Horsmans Y, Lambert P, Danse E, Delzenne NM. Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: Results of a pilot study. Eur J Clin Nutr 2005; 59: 723-726.
21. Forcheron F, Beylot M. Long-term administration of inulin-type fructans has no significant lipid-lowering effect in normolipidemic humans. Metabolism 2007; 56: 1093-1098.
22. Giacco R, Clemente G, Luongo D, Lasorella G, Fiume I, Brouns F, Bornet F, Patti L, Cipriano P, Rivellese A A, Riccardi G. Effects of short-chain fructo oligosaccharides on glucose and lipid metabolism in mild hypercholesterolaemic individuals. Clin Nutr 2004; 23: 331-340.
23. Jackson KG, Taylor GRJ, Clohessy AM, Williams CM. The effect of the daily intake of inulin on fasting lipid, insulin and glucose concentrations in middleaged men and women. Br J Nutr 1999; 82: 23-30.
24. nd edn. Hillsdale, New Jersey: Erlbaum, 1988.
25. Storey D, Lee A, Bornet F, Brouns F. Gastrointestinal tolerance of erythritol and xylitol ingested in a liquid. Eur J Clin Nutr 2007; 61: 349-354.
26. Brighenti F, Casiraghi MC, Canzi E, Ferrari A. Effect of consumption of a ready-to-eat breakfast cereal containing inulin on the intestinal milieu and blood lipids in healthy male volunteers. Eur J Clin Nutr 1999; 53: 726-733.
27. Letexier D, Diriaison F, Beylot M. Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans. Am J Clin Nutr 2003; 77: 559-564.
28. The Canadian physical activity, fitness and lifestyle approach. Canadian Society for Exercise Physiology. Ottawa: Author, 2004.
29. Bertoli S, Cardinali S, Veggiotti P, Trentani C, Testolin G, Tagliabue A. Evaluation of nutritional status in children with refractory epilepsy. Nutr J 2006; 5: 5-14.
30. nd Ed. New York: Oxford University Press, 2005.
31. Global Database on Body Mass Index: World Health Organization, 2009. (Accessed January 31, 2011, at http://apps.who.int/bmi/index.jsp?introPage=intro_3.html.)
32. Fiordaliso M, Kok N, Desager J, Goethals F, Deboyser D, Roberfroid M, Delzenne N. Dietary oligofructose lowers triglycerides, phospholipids and cholesterol in serum and very low density proteins of rats. Lipids 1995; 30: 163-167.
33. Kok N, Roberfroid M, Robert A, Delzenne N. Involvement of lipogenesis in the lower VLLDL secretion induced by oligofructose in rats. Br J Nutr 1996; 76: 881-890.
34. Levrat M, Favier M, Moundras C, Rémésy C, Demigné C, Morand C. Role of dietary propionic acid and bile acid excretion in the hypocholesterolemic effects of oligosaccharides in rats. J Nutr 1994; 124: 531-538.
35. Foster-Powell K, Holt SHA, Brand-Miller JC. International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr 2002; 76: 5-56.
36. Zumbé A, Lee A, Storey D. Technological properties of low digestible carbohydrates. Br J Nutr 2001; 8: S31-S45.
37. Livesey G. Health potentials of polyols as sugar replacers, with emphasis on low glycaemic properties. Nutr Res Rev 2003; 16: 163-191.
38. Beaugerie L, Flourié B, Marteau P, Pellier P, Franchisseur C, Rambaud JC. Digestion and absorption in the human intestine of three sugar alcohols. Gastroenterology 1990; 99: 717-723.
39. de Kalbermatten N, Ravussin E, Maeder E, Geser C, Jequier E, Felber JP. Comparison of glucose, fructose, sorbitol and xylitol utilization in humans during insulin suppression. Metab Clin Exp 1980; 29: 62-67.
40. Natah SS, Hussein JR, Tuominen KA, Koivisto VA. Metabolic response to lactitol and xylitol in healthy men. Am J Clin Nutr 1997; 65: 947-950.
41. Assev S, Waler S M, Rolla G. Further studies on the growth inhibition of some oral bacteria by xylitol. Acta Pathol Microbiol Scand B Microbiol Immunol 1983; 91, 261-265.
42. Deshpande A, Jadad AR. The impact of polyolcontaining chewing gums on dental carries: A systematic review of original randomized controlled trials and observational studies. J Am Dent Assoc 2008; 139: 1602-1614.
43. Hond ED, Geypens B, Ghoos Y. Effect of high performance chicory inulin on constipation. Nutr Res 2000; 20: 731-736.
44. Diabetes Facts: Canadian Diabetes Association, 2009. (Accessed Mar 6, 2011, at http://www.diabetes.ca/about-diabetes/what/facts/.)
45. Brennan CS. Dietary fibre, glycaemic response, and diabetes. Mol Nutr Food Res 2005; 49: 560-570.
46. Fung TT, Hu FB, Pereira MA, Liu S, Stampfer MJ, Colditz GA, Willett WC. Whole-grain intake and the risk of type 2 diabetes: a prospective study in men. Am J Clin Nutr 2002; 76: 535-540.
47. Bonsu N, Johnson CS, McLeod K. Can dietary fructans lower serum glucose? J Diabetes 2010; 1: 1-9.